Directory
>
Michel Detheux
Michel Detheux
Chair Of The Board Of Directors | iTeos Therapeutics
Watertown, Massachusetts, United States
Michel Detheux
Summary
Michel Detheux is a seasoned executive in the biotechnology sector, with over three decades of experience spanning scientific research and business leadership. As the co-founder and CEO of iTeos Therapeutics, he has successfully navigated the company from its inception through significant funding rounds, including a NASDAQ IPO. His strategic acumen is demonstrated through a landmark deal with GlaxoSmithKline, aimed at co-developing innovative cancer therapies. Michel's academic credentials are robust, holding a Ph.D. in Biochemistry and a B.S. in Bioengineering, complemented by a postdoctoral fellowship in Parasitology. He is also an inventor with numerous patents and publications to his name, showcasing his commitment to advancing the field of cancer immunotherapy. His leadership extends beyond iTeos, serving on the boards of various organizations, indicating a strong network and influence in the biotech community. Michel's diverse experience in both startup environments and established organizations positions him as a key player in shaping the future of biopharmaceuticals.
Michel Detheux
Work Experience
Chair Of The Board Of Directors at
EGLE THERAPEUTICS
August 2024 - Present
Chair Of The Board Of Directors at
ONA Therapeutics
September 2021 - Present
Co-founder, President & CEO at
iTeos Therapeutics
March 2019 - Present
Chair Of The Board Of Directors at
INNOSKEL
March 2022 - July 2023
Founder and Managing Director at
MG6A Bioconsulting
January 2012 - February 2019
Co-founder & CEO* at
iTeos Therapeutics
April 2012 - February 2019
Director of the Board* at
BioWin
September 2016 - September 2018
Independent Board Member* at
IMMUNEHEALTH LTD
September 2014 - September 2016
Director, Spin off project at
Ludwig Institute For Cancer Research
December 2010 - April 2012
Director Euroscreen FAST Business Unit at
EuroScreen Építöipari, Kereskedelmi es Szolgaltató Korlatolt Felelössegu Tarsasag
September 2006 - November 2010
Manager, New Business Opportunities at
EuroScreen Építöipari, Kereskedelmi es Szolgaltató Korlatolt Felelössegu Tarsasag
January 2005 - September 2006
Head of Target Discovery at
EuroScreen Építöipari, Kereskedelmi es Szolgaltató Korlatolt Felelössegu Tarsasag
April 1995 - January 2004
Post doctoral fellow at
University of Glasgow Trust
January 1993 - January 1994
Michel Detheux
Education
Solvay Brussels School of Economics and Management , Cepac
January 2001 - January 2002
University of Law, Post Doc
January 1993 - January 1994
UCLouvain, Phd
January 1989 - January 1993
UCLouvain, Chemical Engineer
January 1984 - January 1989
Frequently Asked Questions about Michel Detheux
What is Michel Detheux email address?
Michel Detheux's primary email address is ********@iteostherapeutics.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Michel Detheux work for?
Michel Detheux is a Chair Of The Board Of Directors at iTeos Therapeutics, a company specializing in Commercial physical research.
Where Michel Detheux graduated from?
Michel Detheux holds a degree in Business/Management from Solvay Brussels School of Economics and Management .
How can I directly contact Michel Detheux?
To contact Michel Detheux directly, you can use the email address ********@iteostherapeutics.com. Complete contact information is available upon registration with Muraena.
Who is Michel Detheux?
Michel Detheux is a seasoned executive in the biotechnology sector, with over three decades of experience spanning scientific research and business leadership. As the co-founder and CEO of iTeos Therapeutics, he has successfully navigated the company from its inception through significant funding rounds, including a NASDAQ IPO. His strategic acumen is demonstrated through a landmark deal with GlaxoSmithKline, aimed at co-developing innovative cancer therapies. Michel's academic credentials are robust, holding a Ph.D. in Biochemistry and a B.S. in Bioengineering, complemented by a postdoctoral fellowship in Parasitology. He is also an inventor with numerous patents and publications to his name, showcasing his commitment to advancing the field of cancer immunotherapy. His leadership extends beyond iTeos, serving on the boards of various organizations, indicating a strong network and influence in the biotech community. Michel's diverse experience in both startup environments and established organizations positions him as a key player in shaping the future of biopharmaceuticals.
Michel`s contact details
********@iteostherapeutics.com
******@ona-therapeutics.com
Colleagues
VP, Global Head of CMC
Executive Vice President, Head of Legal and Corporate Secretary
Executive Vice President Human Resources
VP Project Head
Chief Accountant
VP, Medical Affairs
Executive Chairman
Vice President Clinical Development
Vice President, Regulatory Affairs
Vice President & Head of Project Management